Benzodiazepine Initiation Effect on Mortality Among Medicare Beneficiaries Post‐Acute Ischemic Stroke

This study looked at how starting to take benzodiazepines (BZDs) affects survival in older adults after a stroke. BZDs are medications typically used for anxiety, insomnia, and seizures. The study focused on patients 66 years old and older on Medicare and determined whether taking BZDs within 30 days after leaving the hospital increased their risk of dying within 90 days. The study analyzed over 47,000 patients, selecting those with more favorable outcomes, and found that 1.74% began taking BZDs after their stroke. After adjusting for factors like age, gender, race, hospital stay, and dementia, we found that starting BZDs was associated with a higher risk of death. The risk was particularly high in patients 86 years and older and those with dementia. The study concluded that prescribing BZDs to older stroke survivors could substantially raise the risk of death, especially in the oldest and most vulnerable patients.

Authors

Institutions

Publication Details

Journal
Pharmacoepidemiology and Drug Safety
Published
2025-07-24
DOI
https://doi.org/10.1002/pds.70194
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Benzodiazepine Initiation Effect on Mortality Among Medicare Beneficiaries Post‐Acute Ischemic Stroke

Shuo Sun, Sebastien Haneuse, Deborah Blacker, Joseph P. Newhouse et al.
Pharmacoepidemiology and Drug Safety
Dementia and Cognitive Impairment Research
article

Benzodiazepine Initiation Effect on Mortality Among Medicare Beneficiaries Post‐Acute Ischemic Stroke

Shuo Sun, Sebastien Haneuse, Deborah Blacker, Joseph P. Newhouse, Lidia M.V.R. Moura, Maria A. Donahue, Lee H. Schwamm, Madhav Sankaranarayanan, Julianne D. Brooks, John Hsu
article en

Abstract

This study looked at how starting to take benzodiazepines (BZDs) affects survival in older adults after a stroke. BZDs are medications typically used for anxiety, insomnia, and seizures. The study focused on patients 66 years old and older on Medicare and determined whether taking BZDs within 30 days after leaving the hospital increased their risk of dying within 90 days. The study analyzed over 47,000 patients, selecting those with more favorable outcomes, and found that 1.74% began taking BZDs after their stroke. After adjusting for factors like age, gender, race, hospital stay, and dementia, we found that starting BZDs was associated with a higher risk of death. The risk was particularly high in patients 86 years and older and those with dementia. The study concluded that prescribing BZDs to older stroke survivors could substantially raise the risk of death, especially in the oldest and most vulnerable patients.

Pharmacoepidemiology and Drug SafetyVol. 34(8)
National Bureau of Economic Research (US), Harvard University (US), Massachusetts General Hospital (US), Yale New Haven Health System (US)
National Institutes of Health
Good health and well-being
Openalex Percentile: Top 78%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.